Titan Medical Inc. (TMD.TO)
CAD 1.13
(2150.0%)
CAD 1.13
(2150.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.06 USD | 115.79% |
| 2022 | -0.38 USD | -171.43% |
| 2021 | -0.14 USD | 63.16% |
| 2020 | -0.38 USD | 72.46% |
| 2019 | -1.38 USD | -1.47% |
| 2018 | -1.36 USD | 68.0% |
| 2017 | -4.25 USD | 10.9% |
| 2016 | -4.77 USD | 59.98% |
| 2015 | -11.92 USD | -177.86% |
| 2014 | -4.29 USD | -14.4% |
| 2013 | -3.75 USD | -2.74% |
| 2012 | -3.65 USD | 58.19% |
| 2011 | -8.73 USD | -239.69% |
| 2010 | -2.57 USD | -301.56% |
| 2009 | -0.64 USD | 78.23% |
| 2008 | -2.94 USD | -374.19% |
| 2007 | -0.62 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.01 USD | -30.99% |
| 2024 Q1 | -0.01 USD | 75.43% |
| 2023 FY | - USD | 115.79% |
| 2023 Q2 | 0.11 USD | 580.35% |
| 2023 Q4 | -0.03 USD | -4916.67% |
| 2023 Q1 | -0.02 USD | 79.18% |
| 2023 Q3 | 0.00 USD | -99.45% |
| 2022 Q1 | -0.08 USD | -175.36% |
| 2022 Q3 | -0.09 USD | -8.11% |
| 2022 Q4 | -0.11 USD | -21.41% |
| 2022 FY | - USD | -171.43% |
| 2022 Q2 | -0.08 USD | -1.09% |
| 2021 Q4 | 0.11 USD | 237.5% |
| 2021 FY | - USD | 63.16% |
| 2021 Q3 | -0.08 USD | -700.0% |
| 2021 Q1 | -0.15 USD | 40.0% |
| 2021 Q2 | -0.01 USD | 93.33% |
| 2020 Q2 | -0.02 USD | -8.67% |
| 2020 FY | - USD | 72.46% |
| 2020 Q1 | -0.02 USD | -120.07% |
| 2020 Q4 | -0.25 USD | -1125.49% |
| 2020 Q3 | -0.02 USD | -8.51% |
| 2019 Q2 | -0.46 USD | 62.3% |
| 2019 Q3 | -0.05 USD | 89.37% |
| 2019 Q4 | 0.09 USD | 276.28% |
| 2019 FY | - USD | -1.47% |
| 2019 Q1 | -1.22 USD | -212.82% |
| 2018 FY | - USD | 68.0% |
| 2018 Q4 | -0.39 USD | 4.88% |
| 2018 Q3 | -0.41 USD | 4.65% |
| 2018 Q2 | -0.43 USD | -575.04% |
| 2018 Q1 | -0.06 USD | 94.46% |
| 2017 Q3 | -1.65 USD | -450.0% |
| 2017 FY | - USD | 10.9% |
| 2017 Q2 | -0.30 USD | 65.91% |
| 2017 Q1 | -0.88 USD | -144.44% |
| 2017 Q4 | -1.15 USD | 30.3% |
| 2016 Q2 | -1.62 USD | 43.16% |
| 2016 Q1 | -2.85 USD | 21.05% |
| 2016 Q4 | -0.36 USD | -9.09% |
| 2016 Q3 | -0.33 USD | 79.63% |
| 2016 FY | - USD | 59.98% |
| 2015 Q4 | -3.61 USD | -13.52% |
| 2015 FY | - USD | -177.86% |
| 2015 Q1 | -2.67 USD | -3645.82% |
| 2015 Q2 | -2.41 USD | 9.74% |
| 2015 Q3 | -3.18 USD | -31.95% |
| 2014 Q3 | -0.97 USD | 54.25% |
| 2014 Q4 | 0.08 USD | 107.76% |
| 2014 Q2 | -2.12 USD | -50.35% |
| 2014 Q1 | -1.41 USD | -65.88% |
| 2014 FY | - USD | -14.4% |
| 2013 Q3 | -0.88 USD | 5.38% |
| 2013 FY | - USD | -2.74% |
| 2013 Q4 | -0.85 USD | 3.41% |
| 2013 Q2 | -0.93 USD | 15.45% |
| 2013 Q1 | -1.10 USD | -30.95% |
| 2012 Q2 | -0.67 USD | 58.13% |
| 2012 Q4 | -0.84 USD | -58.49% |
| 2012 Q3 | -0.53 USD | 20.9% |
| 2012 Q1 | -1.60 USD | 40.96% |
| 2012 FY | - USD | 58.19% |
| 2011 Q1 | -1.30 USD | -73.33% |
| 2011 FY | - USD | -239.69% |
| 2011 Q4 | -2.71 USD | 11.73% |
| 2011 Q3 | -3.07 USD | -83.83% |
| 2011 Q2 | -1.67 USD | -28.46% |
| 2010 FY | - USD | -301.56% |
| 2010 Q2 | -0.67 USD | -81.08% |
| 2010 Q3 | -0.75 USD | -11.94% |
| 2010 Q4 | -0.75 USD | 0.0% |
| 2010 Q1 | -0.37 USD | 7.5% |
| 2009 Q1 | -0.14 USD | -129.17% |
| 2009 FY | - USD | 78.23% |
| 2009 Q4 | -0.40 USD | -2757.14% |
| 2009 Q3 | -0.01 USD | 81.82% |
| 2009 Q2 | -0.08 USD | 45.0% |
| 2008 Q4 | 0.48 USD | 151.06% |
| 2008 Q2 | -0.78 USD | 0.0% |
| 2008 Q1 | - USD | 100.0% |
| 2008 FY | - USD | -374.19% |
| 2008 Q3 | -0.94 USD | -20.51% |
| 2007 Q3 | -0.02 USD | 0.0% |
| 2007 Q4 | -0.49 USD | -2592.31% |
| 2007 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|